[Federal Register: December 27, 2007 (Volume 72, Number 247)]
[Notices]
[Page 73359]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27de07-75]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this
is notice that on November 7, 2007, Johnson Matthey, Inc.,
Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey
08066-1742, made application by renewal to the Drug Enforcement
Administration (DEA) for registration as an importer of the basic
classes of controlled substances listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phenylacetone (8501)....................... II
Raw Opium (9600)........................... II
Concentrate of Poppy Staw (9670)........... II
------------------------------------------------------------------------
The company plans to import the listed controlled substances as raw
materials for use in the manufacture of bulk controlled substances for
distribution to its customers.
No comments, objections, or requests for any hearings will be
accepted on any application for registration or re-registration to
import crude opium, poppy straw, concentrate of poppy straw, or coca
leaves.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances listed in schedule I or II, which fall under the authority
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may, in
the circumstances set forth in 21 U.S.C. 958(i), file comments or
objections to the issuance of the proposed registration and may, at the
same time, file a written request for a hearing on such application
pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR
1316.47.
Any such comments or objections being sent via regular mail should
be addressed, in quintuplicate, to the Drug Enforcement Administration,
Office of Diversion Control, Federal Register Representative/ODL,
Washington, DC 20537, or any being sent via express mail should be sent
to Drug Enforcement Administration, Office of Diversion Control,
Federal Register Representative/ODL, 8701 Morrissette Drive,
Springfield, VA 22152; and must be filed no later than January 28,
2008.
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR Sec. 1301.34(b),
(c), (d), (e) and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, (40 FR 43745), all applicants
for registration to import a basic class of any controlled substances
in schedule I or II are, and will continue to be, required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and
21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.
Dated: December 18, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-25043 Filed 12-26-07; 8:45 am]
BILLING CODE 4410-09-P